MUSTANG BIO, INC. Interest Expense, Related Party
MUSTANG BIO, INC. (MBIO) reported Interest Expense, Related Party of $2.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Expense Statement
us-gaap:InterestExpenseRelatedParty · last filed 2017-05-15
- MUSTANG BIO, INC. interest expense, related party for the quarter ending 2017-03-31 was $2.00K, a 97.53% decline year-over-year.
- MUSTANG BIO, INC. interest expense, related party for the quarter ending 2016-12-31 was $33.00K.
- MUSTANG BIO, INC. interest expense, related party for the quarter ending 2016-09-30 was $46.00K, a 20.69% decline year-over-year.
- MUSTANG BIO, INC. interest expense, related party for the quarter ending 2016-03-31 was $81.00K.
- MUSTANG BIO, INC. interest expense, related party for fiscal 2016 was $253.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 7 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 10 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|---|---|
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-15 | $35.00K derived: sum of 2 quarters · filed 2017-05-15 | $81.00K derived: sum of 3 quarters · filed 2017-05-15 | |||
| 2016-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $79.00K derived: sum of 2 quarters · filed 2017-03-31 | $253.00K 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $46.00K 10-Q · filed 2016-11-14 | $220.00K 10-Q · filed 2016-11-14 | ||||
| 2016-03-31 | $81.00K 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $168.00K 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | $58.00K 10-Q · filed 2016-11-14 | $100.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |